Abu dhabi: ADCAN Pharma, a leading UAE-based pharmaceutical manufacturer known for being the country's first producer of oncology and hormone products, has announced a formal partnership with Menarini, an international pharmaceutical company headquartered in Italy.
According to Emirates News Agency, the partnership represents a significant milestone for ADCAN Pharma as it expands its role as a regional pharmaceutical manufacturing hub and preferred localisation partner for multinational pharmaceutical companies operating across the GCC. The partnership was formalised during a signing ceremony held at ADCAN Pharma's state-of-the-art manufacturing facility in Abu Dhabi. Under the agreement, ADCAN Pharma will locally manufacture and facilitate the batch release of selected Menarini pharmaceutical products within the UAE, leveraging its advanced Good Manufacturing Practice (GMP) infrastructure and robust regulatory capabilities. Through the combined expertise of both entities, the collaboration will contribute to enhancing medicine availability, reducing supply chain risks, and facilitating faster patient access to critical therapies across the UAE.
Dr. Fokion Sinis, Chief Executive Officer of ADCAN Pharma, stated that the partnership with Menarini aligns with their mission to strengthen the UAE's pharmaceutical manufacturing landscape. By combining Menarini's global expertise with ADCAN Pharma's advanced manufacturing and batch-release capabilities, they aim to support the national vision to nurture a resilient and sustainable pharmaceutical ecosystem. The collaboration also reinforces ADCAN's role as a trusted local manufacturing partner for international pharmaceutical companies, facilitating improved access to high-quality medicines across the region.
The partnership marks Menarini's first pharmaceutical localisation initiative in the UAE, laying the groundwork for future collaborations supporting the regional healthcare sector. The agreement is expected to enhance ADCAN Pharma's manufacturing portfolio, increase production capacity utilisation, and generate new revenue streams while strengthening the company's technical expertise and standing within the global pharmaceutical industry.
Dr. Basel Thaher, Regional Head Middle East and Africa and General Manager of Menarini, expressed that the UAE continues to set a strong benchmark for healthcare innovation, localisation, and long-term sector development. Through the partnership with ADCAN Pharma, Menarini supports the country's vision of building sustainable local pharmaceutical capabilities while ensuring patients have timely access to high-quality medicines. This collaboration combines Menarini's global expertise with ADCAN Pharma's excellence to strengthen supply chain resilience, support healthcare self-sufficiency, and ultimately deliver better outcomes for patients across the UAE.
Through strategic partnerships with global pharmaceutical companies, ADCAN Pharma continues to advance its role as a regional pharma manufacturing and regulatory specialist. Guided by its commitment to innovation, quality, and affordability, the company continues to deliver world-class healthcare solutions across the GCC and international markets, aligning with the 'We the UAE 2031' vision.